Last reviewed · How we verify
NCT05302193
Non-invasive Blood Pressure Measurement Using Samsung Smartwatch
NA trial testing Calm measurement of blood pressure and heart rate (before physical activity) in Blood Pressure in 27 participants. Completed in 30 September 2021.
30 September 2021
Quick facts
| Lead sponsor | Czech Technical University in Prague |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 27 |
| Start date | 1 March 2021 |
| Primary completion | 30 September 2021 |
| Estimated completion | 30 September 2021 |
| Sites | 1 location across Czechia |
Drugs / interventions tested
- Calm measurement of blood pressure and heart rate (before physical activity)
- Physical activity
- Calm measurement of blood pressure and heart rate (after physical activity)
Conditions studied
- Blood Pressure — all drugs for Blood Pressure →
- Heart Rate — all drugs for Heart Rate →
Sponsor
Czech Technical University in Prague
Who can join
15 and older, any sex, with Blood Pressure or Heart Rate. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to verify the accuracy of blood pressure and heart rate measurement by Samsung smartwatches compared to a standard monitor of vital signs used in intensive care units.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05302193
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Blood Pressure
Currently open trials in the same condition.
- NCT07070583 — Impact of Aorto-Iliac Occlusive Disease Treatment on Blood Pressure · NA · recruiting
- NCT07396636 — Machine Learning-Assisted Management of Intraoperative Hypotension for Personalized Treatment · recruiting
- NCT06719518 — Performance Evaluation of the ViTrack Continuous Non-invasive Blood Pressure Measurement Device · recruiting
- NCT07319117 — Evaluation of the Impact of a Nutritional Formulation on Cognitive Performance Following Stress Exposure. · NA · recruiting
- NCT06837181 — Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM) · recruiting
Other Czech Technical University in Prague trials
Trials by the same sponsor.
- NCT06817850 — Neonatal Oximeter Bias Study · not yet recruiting
- NCT06626217 — Comparison of Perfusion Index Monitoring Using a Smartwatch and a Pulse Oximeter · NA · not yet recruiting
- NCT06635018 — Effect of Pulse Oximeter Device on Measured Perfusion Index Values · NA · completed
- NCT06098092 — Long-term Accuracy and Stability of Blood Pressure Measurements From a Smartwatch: Prospective Validation Study · NA · completed
- NCT05929196 — Feasibility Evaluation - Blood Glucose Level Monitoring by Microwave Metamaterial Sensor in Blood Samples. · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05302193 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Czech Technical University in Prague
- Last refreshed: 25 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05302193.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing